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Background: In British Columbia (BC), understanding of high-risk drug use trends is largely based on survey and
cohort study data from two major cities, which may not be representative of persons who use drugs in other regions.
Harm reduction stakeholders, representing each of the five geographic health regions in BC, identified a need for data
on drug use to inform local and regional harm reduction activities across the province. The aims of this project were to
(1) develop a drug use survey that could be feasibly administered at harm reduction (HR) sites across all health regions
and (2) assess the data for differences in reported drug use frequencies by region.
Methods: A pilot survey focusing on current drug use was developed with stakeholders and administered among clients
at 28 HR supply distribution sites across the province by existing staff and peers. Data were collated and analysed using
univariate and bivariate descriptive statistics to assess differences in reported drug use frequencies by geography. A
post-survey evaluation was conducted to assess acceptability and feasibility of the survey process for participating sites.
Results: Crack cocaine, heroin, and morphine were the most frequently reported drugs with notable regional
differences. Polysubstance use was common among respondents (70%) with one region having 81% polysubstance
use. Respondents surveyed in or near their region's major centre were more likely to report having used crack cocaine
(p < 0.0001) and heroin (p < 0.0001) in the past week as compared to those residing >50 km from the major centre.
Participants accessing services >50 km from the regional centre were more likely to have used morphine (p < 0.0001).
There was no difference in powder cocaine use by client/site proximity to the regional centre. Participating sites found
the survey process acceptable, feasible to administer annually, and useful for responding to client needs.
Conclusions: The survey was a feasible way for harm reduction sites across BC to obtain drug use data from clients
who actively use drugs. Drug use frequencies differed substantially by region and community proximity to the regional
centre, underlining the need for locally collected data to inform service planning.
Keywords: Harm reduction, Persons who use drugs, Survey, SurveillanceBackground
Illicit drug use is a major contributor to premature mor-
tality and preventable morbidity and disability worldwide
[1]. In Canada, there is geographic variation in drug use
often based on regional drug trafficking activities affecting
drug availability [2,3]. In the past decade, there has been
increasing prevalence of crack cocaine smoking and de-
creased use of heroin outside of major port cities with a* Correspondence: margot.kuo@bccdc.ca
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unless otherwise stated.concurrent increase in the use of diverted prescription
opioids [4-6]. Changes in drug supply and method of use
may put persons who use drugs (PWUD) at higher risk of
overdose and other harms due to lack of familiarity with a
new drug's potency and health risks [7].
In British Columbia (BC), there is monitoring of drug
use trends and harms experienced among high-risk pop-
ulations. Drug information is collected in the context of
cohort studies or cross-sectional surveys in sentinel city
sites. Long-running cohort studies include the Vancouver
Injection Drug Use Study, which assesses health status of
persons who inject drugs (PWID) in Vancouver [8]. The. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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on at-risk youth in Vancouver aged 14–26 years [9]. The
Cedar Project is a prospective cohort study of young
aboriginal persons in Vancouver and Prince George
[10]. The High Risk Populations survey, conducted in
Vancouver and Victoria by The Centre for Addictions
Research (CARBC), provides semi-annual indicators of
drug use patterns and harms experienced in three at-risk
populations: recreational/party attendees, street-involved
youth, and street-involved adults [11].
In Canada, there are two nationally coordinated cross-
sectional surveys, I-track and M-track focusing on PWID
and men who have sex with men, respectively [12]. This
work provides valuable assessment of risk factors for
communicable disease transmission and other harms.
The US Centers for Disease Control guidelines for
evaluating public health surveillance systems outline
seven key attributes: simplicity, flexibility, acceptability,
sensitivity, positive predictive value, representativeness,
and timeliness [13]. Fielden and Marsh reported that
Canadian drug use systems are neither timely enough
for response to emerging hazards nor representative of
areas outside of major metropolitan centres [14]. In BC,
stakeholders in the area of harm reduction identified a
gap in knowledge regarding drug use patterns and
harms experienced by PWUD outside the major cities of
Vancouver and Victoria. Knowledge of drug use trends
in different areas of the province is needed to optimize
area-level harm reduction (HR) services and to inform
public health responses to prevalent drug-related issues.
The provincial Harm Reduction Program is supported by
the BC Ministry of Health and overseen by the BC Harm
Reduction Strategies and Services (HRSS) Committee,
with health authority HR coordinators from each of the
five geographic health authorities, First Nations Health
Authority, and BC Ministry of Health and managed by
the BC Centre for Disease Control (BCCDC) [15]. The
programme aims to reduce infectious diseases and other
drug-related harms among PWUD and other vulnerable
populations, such as survival sex workers, by distributing
supplies for safer sex, injection, and inhalation practices.
There is a network of over 200 HR sites that order
supplies directly from the provincial programme in
communities of each of the five geographic health
authorities (range 15–110) with satellite sites obtaining
supplies from the ordering sites [16]. HR sites may be
located at public health units or community service
organizations, and HR stakeholders may include public
health practitioners, community members, and supply
distribution site staff and peers.
We endeavored to develop a simple survey tool for the
collection of drug use data from HR clients, leveraging
the existing supply distribution network to pilot the
survey. The main objectives of this pilot survey were toidentify substances commonly used by HR site clients
in BC's five health regions and assess for geographic
differences in drug use. A secondary objective was to
compare the pilot survey data collected from various
communities in each health region with an established
cross-sectional survey which collects data in the major
cities of Vancouver and Victoria.
Methods
The 2012 survey tool was collaboratively designed with
extensive input from provincial HR stakeholders through
a series of working group meetings. An environmental
scan was conducted to identify existing domestic and
international surveys focusing on active drug use. Estab-
lished drug survey tools were reviewed, and the working
group prioritized the information to be collected and
determined the survey format, question phrasing, and
logistics of survey administration. The focus of the survey
was current drug use among HR clients (i.e. the 7 days
prior to participating in the survey) (Table 1).
We utilized a two-stage convenience sampling method;
sites were suggested by the regional HR coordinators
based on capacity and willingness to participate. A total
of 28 sites agreed to participate in the 2012 pilot survey,
with four to six participating sites in each of the five
regions (Figure 1). Site staff and peers then approached
HR clients to invite participation.
The HR sites were contacted to discuss capacity and
process for undertaking the survey. It was important
that the survey be feasible for resource-limited HR sites
to implement on a regular basis. A priori, pilot site staff
were asked to identify criteria for feasibility for biannual
or annual survey participation. From this, an acceptability
questionnaire was developed to be administered to site
groups after the survey was complete (Table 2). Addition-
ally, staff and peers administering the survey to clients
were contacted after the pilot to provide specific input on
how individual questions were received by clients and
feedback on how to improve the wording and administra-
tion of the survey. The process was open to all feedback
on an ongoing basis during and after the survey period.
The survey materials were mailed out, and a 2-week
period of data collection was designated. Each site received
funding, $7 per survey, for client participation incentive
and incidental costs, but the logistics of survey admin-
istration and handling of the participant incentives were
determined at the site level. Most sites opted to provide
participants $5–$7, while others provided the equivalent
in coupons for meals or services. A few sites also used
a portion of the funding to augment their regular provi-
sions, such as fresh fruit or socks, for all who came in
whether they participated or not. Peers are PWUD, cur-
rently or formerly, who assist service agencies with client
engagement. Peer and staff interviewers were identified by
Table 1 Survey summary
Description Questions
Page 1 Consisted of the following questions
(paraphrased, multiple answer choices not provided)
Is this the first time you have used this supply pick up site?
Gender?
Age?
Who are you picking up supplies for?
Have you used the services of other supply pick-up sites?
In the past 7 days, have you consumed alcohol not sold in a liquor store?
If you used rigs in the past 7 days, how did you get rid of them?
Page 2 Asked about drugs used in the past 7 daysa
(number of days used, method of use, doses(hits)















Summary of the 2012 Survey Tool. aPolysubstance use was defined as using ≥2 drugs from the list above and included other drugs not listed but identified in the
final question; polysubstance use excluded marijuana and alcohol. Source: 2012 HR Drug Use Survey, BC Harm Reduction Strategies and Services.
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materials. Training consisted of a pilot survey administra-
tion guide which provided the project framework, steps
for obtaining verbal informed consent, and a script for
phrasing each question.
HR clients were invited to participate if they were
current clients of the site, 19 years or older, capable of
giving verbal informed consent, had used any drugs
(self-defined) in the prior 7 days, and had not participated
in the survey previously. BC harm reduction sites are
low-barrier environments in which clients are not asked
for their names, age, or other personal information;
government identification or healthcare cards; to exchange
used needles/syringes to obtain clean ones; or, generally, to
fill out forms. To maintain this approach, the survey was
anonymous and no client information was linked to survey
responses. Peers administering the survey reviewed the
ethics-approved informed consent information with clients,
confirmed understanding, and obtained verbal agreement
as consent to participate, thus no signature was required.
Participants were informed that they could decline any
question and/or stop at any time and would not be asked
about their decision nor would declining any part of the
survey affect completing other questions, receiving the
stipend, or receipt of any services.The survey tool was two pages long and took approxi-
mately 10 min to administer by a peer or staff interviewer
(Table 1). The first page collected basic demographics
and information on HR site use, needle disposal practices,
and consumption of non-beverage alcohol-containing
products (alcohol not sold in a liquor store such as
rubbing alcohol, hand sanitizer/microsan, mouthwash,
cologne/after shave, hairspray, vanilla extract, cleaning
products) [17]. The question on non-beverage alcohol
was included due to stakeholder interest in assessing
of crossover of the HR client site population with the
illicit drinking population. The second page focused
on type of drug(s) used in the past 7 days.
Using standard Canadian assessment tools which assess
rurality/urbanicity, most BC communities are categorized
as ‘urban’ due to the centralization of urban fringe and
rural postal codes [18]. There are potential differences
in drug distribution/availability between larger regional
centres and those communities distant from larger centres.
Further, most problem drug users, particularly the more
marginalized, have limited financial means which may
preclude travelling for longer durations or distances to
obtain either drugs or HR supplies [19].
To explore possible differences in drug use, based on
availability, between sites in the major regional centre and
Figure 1 Map of sites. Harm reduction sites participating in Harm Reduction Client Drug Survey, 2012 (N = 28).
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according to distance from the health region's most
populace city. We used a geographic information system,
ArcGIS v.10.0 (ESRI, Redlands, CA, USA) to measure the
distances from a point in the geographic centre of each
major city to the geocoded points based on site addresses
of that region. Using 50 km as the cutoff, we identified
13 sites ≤50 km and 15 sites >50 km from the health
authorities major centre. An analytic decision was made
to categorize two sites which mapped to within 50 km
of the major centre as being outside of the major
centre, as these sites almost exclusively served clients
coming in from >50 km away from the city centre, based
on site staff knowledge of client patronage.
Polysubstance use is a term with varying definitions
[20]. We defined polysubstance use as having used two
or more substances in the 7 days prior to the survey
administration. For simplicity of questioning, we did
not assess if use was simultaneous, within severalhours, or days of each other. A list of common drugs
was provided on the survey (Table 1, page 2), and the
respondents were also asked about any other drugs
they had used that did not appear on the list. Alcohol
and marijuana were excluded from the list due to their
presumed overall high prevalence and stakeholder
interest at the time. We asked respondents to name all
drugs they took in the prior 7-day period, regardless
of whether or not there was a prescription, and did
not record the presence or absence of a prescription
for any drugs named.
CARBC provided substance use and prevalence data,
also based on reported use in the past 7 days, from the
2012 Vancouver and Victoria surveys of street-involved
adults. There were two data collection waves in 2012 in
which the aim is to recruit 50 street-involved adults from
both Vancouver and Victoria. In 2012, there were 257
CARBC survey participants asked about alcohol and drug
use. Pearson chi-square was used to test for differences in
Table 2 Post-pilot survey summary
Description Feedback
Part 1 Consisted of 7 statements to be rated on a Likert scale: 1. We would be willing to do the survey again next year
(once per year).
☐ Strongly agree 2. We would consider doing the survey twice per year.
☐ Agree
☐ Neutral 3. The questions were easy to understand and answer.
☐ Disagree
☐ Strongly disagree 4. The staff and peers involved with the survey felt it was
valuable information.
5. The administration of the survey to clients was minimally
disruptive to our regular activities.
6. We estimate the decline/refusal rate was within acceptable
limits (under 15%).
7. Administration of the survey to clients by staff or peers is
preferred over self-administration.
Part 2 Consisted of three open-ended statements for completion 1. What went well for us
2. What did not go so well
3. Suggestions for improvement
Part 3 Consisted of contacting select staff and peers who had administered
the survey for feedback on wording of individual questions, how
questions were received by clients, and suggestions for improvement
Summary of 2012 post-pilot survey of staff and peers.
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pilot survey group for crack, heroin, morphine, cocaine,
crystal methamphetamine, and amphetamines.
Survey data were entered into Microsoft® Office Access
2003. Data manipulation and statistical analyses were con-
ducted in SAS® version 9.3. Graphs summarizing survey
data were created in Microsoft® Excel 2003. All geocoding,
spatial data analysis, and maps were conducted using
ArcGIS v10.0 (ESRI, Redlands, CA, USA). The analysis
focused on univariate and bivariate descriptive statistics
of each question and reported drug frequencies; as well
comparisons between health regions and by site/client
proximity to a major centre. Chi-square tests were used
for comparison of categorical data, and independent t
tests were used for continuous data.
This project was approved by the University of British
Columbia Behavioural Research Ethics Board and other
relevant local boards.
Results
There were 743 clients who completed the first page of
the survey. Of these, 698 (93.9%) went on to complete
the second page (drugs used in the past 7 days) (Table 3).Table 3 Number of respondents by region
Interior Fraser
Number of respondents completing page 1 (row%) 188 (25.3%) 163 (21.9
Number of respondents completing page 2 (row%) 178 (25.5%) 161 (23.1
Number of survey respondents completing pages 1 and 2 of the BC Harm ReductioOf the 743 respondents, 449 (60.8%) were male and 289
(39.1%) were female (1 transgendered; 3 sex missing).
Males were older (p = 0.036), with a mean age of 42.6 years
(range 19–74) compared to 40.0 years among females
(range 19–80) (Figure 2).
Among respondents picking up harm reduction sup-
plies from the site at the time of the survey, 42% were
collecting supplies for themselves, 42% for themselves
and others, 4% only for others, and 11% did not answer
the question. Most respondents (76%) were repeat clients
at the site where they were surveyed.
The majority of respondents (92%) reported that they
had not consumed non-beverage alcohol, 6% reported
they had, and 2% did not answer the question.
The level of safety of reported needle disposal methods
among the 299 individuals who had disposed of needles in
the prior 7-day period was positive with 78% categorized
as safe (e.g. return to site, needle disposal container), 13%
as somewhat safe (e.g. alternate closed container, garbage),
and 9% as not safe (e.g. street, not sure).
The prevalence of drugs used in the prior 7-day period
was compiled by type of drug, among all respondents
and by health region. Crack cocaine use was reported byVancouver coastal Vancouver Island Northern Total
%) 145 (19.5%) 129 (17.4%) 118 (15.9%) 743 (100%)
%) 141 (20.2%) 127 (18.2%) 91 (13.0%) 698 (100%)























Figure 2 Age-sex distribution. Sex and age distribution of survey respondents, BC, 2012 (N = 739). One transgendered respondent and three
respondents missing sex data were omitted from this figure.
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used morphine, and 26% had used cocaine (Figure 3).
The final survey question asked respondents if, in the
prior 7 days, they had used any other drugs not listed in
the survey. A key purpose of this question was to assess if
any frequently taken drugs were excluded from the main
list. As the final question, only a subset of respondents
answered this question. Among those that responded to
this question, marijuana and alcohol were most frequently
reported but 23 persons reported a variety of other drugs
such as diazepam, gabapentin, amitriptyline, acetamino-
phen, acetaminophen/codeine, seroquel, among others.
Crack was found to be the most common drug reported
among respondents in three of the five regional health au-
thorities (Figure 4)—Vancouver Coastal, Vancouver Island,
and Northern Health Authorities. In the Interior health
region, heroin and morphine use were slightly higher than
crack use. A high proportion of Fraser respondents re-
ported heroin use, followed by crack, with comparatively
































Figure 3 Overall drug frequencies. Percentage of respondents reportingrespondents had the highest proportion of morphine
use, and this was the only health region in which powder
cocaine use was higher than heroin use.
Drug use among respondents within 50 km of the major
centre differed from those 50 km or more away (Figure 5).
There was more crack and heroin use among respon-
dents of sites in or near major centres (p < 0.0001 and
p < 0.0001, respectively). Morphine use was found to be
significantly greater among respondents accessing harm
reduction at >50 km away from a major centre (p < 0.0001).
There was no significant difference in the reported use
of powder cocaine between the two defined populations
(p = 0.4708).
Polysubstance use was common among HR clients
surveyed in all health authorities (mean 69.9%; range
64.0%–81.1%) (Figure 6). Vancouver Island had the highest
prevalence of polysubstance use (81.1%) and a notably high
prevalence of reporting of greater than three substances
used in the last 7 days (37.0%). Northern had the second




















crack heroin morphine cocaine
Figure 4 Four drugs by health region. Percentage of respondents reporting use of crack cocaine, heroin, morphine, and powder cocaine by
health region, BC, 2012 (N = 698).
Kuo et al. Harm Reduction Journal 2014, 11:13 Page 7 of 11
http://www.harmreductionjournal.com/content/11/1/13within last 7 days (27.8%). Among the 304 respondents
who reported use of heroin in the prior 7-day period, 84%
also used another substance in the same 7-day period: 54%
reported use of crack, 31% reported use of methadone,
and 24% and 23% reported use of cocaine and morphine,
respectively.
We compared the findings of the 2012 CARBC High
Risk Drug Survey among street-involved adults to our
survey findings. Among HR clients responding to this
survey, the prevalence of crack use was lower (p= 0.0004),
while both heroin and morphine use was higher (p < 0.0001;
p < 0.0001, respectively) than the CARBC survey respon-
dents in Vancouver and Victoria (Table 4).
In the post-survey questionnaire (Figure 7), pilot sites
were in agreement with running the survey once each
year, but fewer felt that it was feasible twice per year.
Approximately 70% of the sites found the survey wording
of questions clear; those sites that did not find the word-
ing of all questions clear were asked for further input


































Figure 5 Four drugs by distance from the major centre. Percentage of
powder cocaine by distance from the major centre, BC, 2012 (N = 698).valued the information covered by the survey questions
for their own knowledge and planning. Over 80% of the
sites found the process non-disruptive, while others
provided input into making the process less disruptive.
Sites with low supply distribution volumes and staff
numbers generally found it more challenging to admin-
ister the survey, but this also depended on the service
model. Subjective refusal and non-completion levels
were universally felt to be very low and acceptable, and
this was attributed to the stipend offered to clients for
their participation. Over 80% of sites reported that sur-
vey administration by site staff or peers (versus self-
administration by clients) was necessary for both data
quality and to maintain other benefits such as rapport
building with clients.
Many sites reported that the survey process offered an
opportunity for engagement and rapport building with
clients as well as a way for staff to learn more about what
is going on at street level and to identify areas of need.
The anonymous nature of the survey and administrationmorphine cocaine
entre >50km from major centre





single drug 36.0 34.2 29.8 18.9 26.7
two drugs 30.3 26.1 31.9 26.8 26.7
three drugs 15.7 19.9 18.4 17.3 18.9




















Figure 6 Polysubstance use. Polysubstance use among survey respondents by health region, BC, 2012 (N = 698). Polysubstance use was defined
as using ≥2 listed drugs (marijuana and alcohol excluded).
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ticipation and accurate responses. Site staff reported that
the survey asked timely and relevant questions and can be
used to ask questions of local interest.
However, there were challenges in administering the
survey in winter (January/February) in Northern when
client volumes were low (stocking up on supplies is more
common when travel is restricted) and in sites with a
small number of staff such that leveraging of students and
volunteers was required. Sites reported that asking clients
to estimate the amount of drug used ‘per hit’ for each drug
reported was problematic.
Suggestions for improvement included the following:
placing alcohol and cannabis on the main drug list in order
to assess risk behaviours around combining particular
drugs with alcohol; assessing simultaneous use of alcohol
(i.e. taken at the same time or within several hours) with
particular drugs, such as opiates; and asking about OD
witnessing and experiences. It was felt that the ongoing
use of peers is important to continue to improve clarity ofTable 4 CARBC comparison
2012 CARBC drug
survey (N = 257) last
7 days (%)
2012 HR drug
survey (N = 698)
last 7 days (%)
p value
Crack 63.04 50.14 0.0004
Heroin 21.40 43.55 <0.0001
Morphine 14.01 29.80 <0.0001
Cocaine 21.40 25.64 0.1761
Crystal meth 18.29 16.62 0.5430
Amphetamine 3.11 3.30 0.8875
Percentage of respondents reporting use of crack cocaine, heroin, morphine,
and powder cocaine by distance from the major centre, BC, 2012 (N = 698).
CARBC, Centre for Addictions Research of BC; HR, harm reduction.the wording of survey. Finally, site staff and peers sug-
gested that a video on survey administration would be an
effective training tool.
Discussion
This survey provided data on drug use in a sample of
harm reduction clients who actively use drugs from each
of BC's five geographic health regions using a simple
survey tool. Differences in the most common drugs used
and levels of polysubstance use were found between sites
and health regions, and based on community distance to
the regional centre. With further development, this survey
approach may inform HR stakeholders about client drug
use with the aim of optimizing regional and local services
for the prevention of drug-related harms. That drug use
differed substantially by sites, regions, and community
type is an important finding underlining the need for
locally collected data to inform service planning. While
the survey is not community-based, the tool may be
customized to collect information on topical local or
regional issues.
Overall, crack was the most commonly reported drug
used, followed by heroin then morphine.
Canadian cohort data has long indicated major in-
creases in crack use over time and that crack is now the
most prevalent drug used in many major metropolitan
areas [6,21]. We also found that respondents from sites
in or near the major centre had a higher prevalence of
crack use. Many studies have reported that persons who
use crack are among the most socio-economically mar-
ginalized groups and are associated with high rates of
homelessness, polysubstance use, and HIV and/or HCV
co-infection [21-24]. However, compared with CARBC data
from BC's two major cities, we found a lower prevalence of






















Figure 7 Post-pilot survey. Post-pilot survey responses BC, (N = 28 HR sites). See Figure 3 for complete statements and Likert scale.
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supplies are available.
Fischer et al. report that there are fewer established
supports in BC for persons who smoke crack as compared
to persons with opioid dependence or injection drug use
[22]. We found >50% prevalence of crack smoking among
harm reduction clients surveyed. Currently, the BC Harm
Reduction Program does not provide glass stems (crack
pipes) for safer crack use in their supply distribution
(though some health regions support distribution at
specific local sites) nor have safe inhalation sites been
evaluated for implementation in BC [25,26].
Another proposed risk reduction measure for persons
who smoke crack is the co-use of cannabis in order to
manage psycho-stimulant effects [27]. Further iterations
of the survey will include questions to evaluate access to
glass stems (sharing, use of makeshift pipes), access to
safe locations for illicit smoking, and the prevalence of
co-use of cannabis as a harm reduction measure.
Northern was the only health region in which the re-
ported use of morphine was higher than that of heroin.
There was more heroin use among respondents at sites
closer to the major centre versus more morphine use at
those further away. These finding are in keeping with
evidence that prescription opioids diverted for illicit use
is a growing problem in Canada [4-6]. Fischer et al.
found evidence that heroin has become an increasingly
marginal drug used among illicit opioid users in Canada,
particularly outside of major port cities thought to be
heroin import points, such as Montreal and Vancouver [4].
To better understand the level of diversion of prescription
opioids, future surveys will ask about whether or not clients
had a prescription for drugs reported.
We identified key gaps in our survey to be addressed
in future iterations. These included the inability to assess
(1) alcohol and marijuana use, (2) the concurrent use of
drugs, and (3) overdose. In 2006, Buxton et al. assessed
a year of coroner's data on drug overdose deaths inBC [28]. In 34.5% of cases, there were three or more
substances detected. In our study, 41.4% of the overall
sample reported three or more substances used in the
prior 7 days, although our definition excluded alcohol
and marijuana. Among overdose deaths in 2006, cocaine
was identified in 80.3% and opiates in 59.6% of deaths,
with opioids more frequently identified in Vancouver
(74.1%) compared to outside Vancouver (55.0%). Both
morphine and cocaine were detected in 44.4% of
deaths (55.3% of cocaine-positive cases). Alcohol was
detected in 22.6% opiate-positive cases. As combining
alcohol with opiates plays a clear role in respiratory
depression, including alcohol is important in assessing
overdose risk and educational needs among harm reduc-
tion clients. Understanding polysubstance use trends is
important to planning BC's public health interventions
for overdose.
Reported polysubstance use (≥2 substances) was highest
in Northern and Vancouver Island health regions. The
Northern health region is remotely located from Vancouver,
as BC's port city, and Vancouver Island health region is sep-
arated from the mainland, requiring ferry transport. This
could potentially affect the availability of particular drugs
such as heroin [2-4]. Identifying areas of high opioid and
polysubstance use allows strategic rollout of overdose pre-
vention initiatives such as BC's recently initiated Take
Home Naloxone Program [29].
This first survey implementation and evaluation have
provided valuable refinements to future data collection,
including (1) adding alcohol and marijuana to the drug list,
(2) specifically asking about concurrent drug combinations
(within 6 h of each other), and (3) adding specific questions
on client residence/distance travelled to site, sharing nee-
dles, drug overdose, prescriptions, and crack pipe access.
For practicality, we used a small convenience sample
to pilot this survey. Due to site self-selection, the low
number of sites per health region, and mixed urbanity/
rurality of the sites, the collated data from all participating
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region as a whole. The goal of future surveys is to expand
to more sites throughout the province, which will improve
regional representativeness. However, each site can benefit
from receiving the summary of its own data. Going for-
ward, data aggregated at the regional level may contribute
to major initiatives coordinated at the regional level, and
local data will be required for local service planning.
Survey findings are limited to harm reduction clients
and thus may not represent PWUD who do not access
harm reduction sites (e.g. mainstream youth or who
have supplies picked up by a friend). As we are asking
clients about their drug use in the recent past, recall bias
and social acceptability bias may play roles in underre-
porting of certain drug use.
Conclusion
Pilot survey data showed differences in drug use among
harm reduction clients by region and by proximity to a
major centre. That drug use differed substantially by sites,
regions, and community type is an important finding
underlining the need for locally collected data to inform
service planning. Differences in drug use trends found
between this survey and established surveys further the
hypothesis that information on drug use from regions
outside of the major metropolitan regions is of value in
planning prevention activities in other regions of the
province.
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